UTSW & the Move to Patient-Centricity-based Clinical Trials in the Age of COVID-19
COVID-19 has led to a wave of new rules and a new set of expectations involving clinical trials as research […]
COVID-19 has led to a wave of new rules and a new set of expectations involving clinical trials as research […]
UT Southwestern Medical Center researchers are investigating existing, available drugs that could potentially help treat mild to moderate COVID-19 cases. […]
UT Southwestern is on the move, taking on COVID-19 in a number of ways. Recently, Dallas Innovates showcased five core […]
University of Texas Southwestern Medical Center researchers have identified a potential COVID-19 treatment in preclinical research activity targeting COVID-19, and […]
Taysha Gene Therapies just emerged out of stealth mode with a $30 million seed round and a strategic partnership with UT […]
Because delays or lags in the time it takes a clinical investigational site to activate a clinical trial can have […]
University of Texas Southwestern (UTSW) inked a collaborative research deal with Recombinetics (RCI) to identify key factors that improve the […]
Using human lung cancer cells, UT Southwestern researchers have uncovered how cells in general modulate their energy consumption based on […]
UT Southwestern Simmons Cancer Center researchers have discovered a two-drug combination that halts the growth of cancer cells that carry […]
Federal regulations could be getting in the way of life and death as cancer patients in dire need of help […]